CLLS Competitors & Alternatives
Compare Cellectis SA with similar stocks in the same industry
Biotechnology
CLLS
Main Stock$0.98
Tradestie Score
46
Market Cap
$330.07M
Revenue Growth
-0.6%
Analyst Upside
+392.3%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$6.93
|
$170.45M | - | 42 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.49
|
$158.43M | - | 59 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.05
|
$154.27M | - | 43 | Compare |
|
FATE
Fate Therapeutics, Inc.
|
$2.11
|
$144.16M | - | 48 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.19
|
$133.50M | - | 63 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.49
|
$114.01M | - | 63 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.97
|
$110.20M | - | 57 | Compare |
|
ATRA
Atara Biotherapeutics, Inc
|
$8.59
|
$101.48M | - | 40 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.92
|
$84.52M | - | 42 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.15
|
$67.94M | - | 60 | Compare |
More CLLS Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2836)
224 stocks in this industry